Shui Ping Tu
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cell death mechanisms and regulation 5
- Ubiquitin and proteasome pathways 4
- Cancer-related gene regulation 2
- Oncology 9
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 3
- Co-authors
- Timothy C. Wang (8 shared papers)Michael Quante (4 shared papers)Wataru Shibata (2 shared papers)Kelly S. Betz (2 shared papers)Sophie S.W. Wang (2 shared papers)Gwang Ho Baik (2 shared papers)Hiroyuki Tomita (1 shared paper)Andrea Varró (1 shared paper)
- Journals
- Gastroenterology (4 papers)Cancer Letters (2 papers)Laboratory Investigation (2 papers)Oncotarget (2 papers)Carcinogenesis (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shui Ping Tu
23 papers receiving 2.1k citations
Shui Ping Tu's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 838
- Cancer Research 370
- Genetics 210
- Immunology 378
- Molecular Biology 886
Countries citing papers authored by Shui Ping Tu
This map shows the geographic impact of Shui Ping Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui Ping Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui Ping Tu more than expected).
Fields of papers citing papers by Shui Ping Tu
This network shows the impact of papers produced by Shui Ping Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui Ping Tu. The network helps show where Shui Ping Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shui Ping Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth Hit paper breakdown → | 2011 | 854 |
| 2 | Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. | 2003 | 145 |
| 3 | 2011 | 142 | |
| 4 | 2016 | 106 | |
| 5 | 2011 | 100 | |
| 6 | 2004 | 98 | |
| 7 | 2006 | 88 | |
| 8 | 2008 | 82 | |
| 9 | 2005 | 72 | |
| 10 | 2003 | 50 | |
| 11 | 2014 | 50 | |
| 12 | 2009 | 38 | |
| 13 | 2009 | 36 | |
| 14 | 2013 | 32 | |
| 15 | 2011 | 31 | |
| 16 | 2010 | 30 | |
| 17 | 2003 | 29 | |
| 18 | 2009 | 29 | |
| 19 | 2016 | 27 | |
| 20 | 2018 | 16 |
About Shui Ping Tu
Shui Ping Tu is a scholar working on Molecular Biology, Oncology, Surgery, Genetics and Pathology and Forensic Medicine, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Cells and Metastasis (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cancer-related gene regulation (2 papers), Immune cells in cancer (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Oncology (838 citations), Cancer Research (370 citations), Genetics (210 citations), Immunology (378 citations) and Molecular Biology (886 citations). Shui Ping Tu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Timothy C. Wang, Michael Quante, Wataru Shibata, Kelly S. Betz, Sophie S.W. Wang, Gwang Ho Baik, Hiroyuki Tomita, Andrea Varró, Richard A. Friedman and Bethany L. DiPrete. Their work appears in journals such as Gastroenterology, Cancer Letters, Laboratory Investigation, Oncotarget and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.